Human Papillomavirus Vaccination Uptake in the Rio Grande Valley: Results from a Pilot Community-Based Educational and School-Based Vaccination Program and Its Expansion
Open Access
Abstract
Human papillomavirus (HPV) vaccine is a safe and effective strategy for reducing HPV morbidity and mortality. Schools have become an increasingly attractive setting for delivering vaccinations and supporting vaccination health literacy and decisional support. This study assesses the effectiveness of a community-based, physician-led HPV education campaign (starting in 2016) and onsite middle school-based HPV vaccination program across six school districts (2017, 2019, 2020) in a rural, medically underserved Texas area (Rio Grande Valley). Pre- and post-intervention HPV vaccination rates were tracked against the 2016 National Immunization Survey—Teen target rates (initiation: 49.3%; completion: 32.9%). Summary statistics were stratified by gender, school district, and grade level. The study reached 19,951 students who received HPV vaccines directly or indirectly through our program (10,289 females; 9662 males) (August 2016–August 2022). Of those, 2145 students (1074 females; 1071 males) were vaccinated directly through our program. The overall HPV up-to-date (UTD) rates were 58.8%. The overall median age at HPV vaccine initiation and HPV-UTD (range) was 11 years (9–21) and 12 years (9–20). The overall median interval between HPV vaccine doses (range) was 291 days (146–2968). Recommending HPV vaccine initiation at younger ages increases HPV vaccine completion and providing access to HPV vaccines encourages on-time vaccination and completion.Keywords
Funding Information
- National Institutes of Health (UL1 TR001439, PP160097, PP190023, PP200057)
- University of Texas MD Anderson Cancer Center’s HPV Vaccination Initiative (UL1 TR001439, PP160097, PP190023, PP200057)
- Cancer Prevention and Research Institute of Texas (UL1 TR001439, PP160097, PP190023, PP200057)
This publication has 34 references indexed in Scilit:
- Improving vaccination uptake among adolescentsCochrane Database of Systematic Reviews, 2015
- HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescentsBMC Public Health, 2015
- Human papillomavirus vaccine initiation among 9–13-year-olds in the United StatesPreventive Medicine Reports, 2015
- Determinants of Acceptance and Subsequent Uptake of the HPV Vaccine in a Cohort in Eldoret, KenyaPLOS ONE, 2014
- Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sonsVaccine, 2014
- Literature review of HPV vaccine delivery strategies: Considerations for school- and non-school based immunization programVaccine, 2014
- Promising alternative settings for HPV vaccination of US adolescentsExpert Review of Vaccines, 2013
- Human papillomavirus vaccine uptake and barriers: Association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010Vaccine, 2011
- A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptabilityVaccine, 2010
- HPV Vaccine Acceptance among Latina Mothers by HPV StatusJournal of Women's Health, 2009